AbbVie (Brazil) Analysis

ABBV34 Stock  BRL 69.32  2.53  3.79%   
AbbVie Inc is overvalued with Real Value of 57.4 and Hype Value of 69.32. The main objective of AbbVie stock analysis is to determine its intrinsic value, which is an estimate of what AbbVie Inc is worth, separate from its market price. There are two main types of AbbVie's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect AbbVie's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of AbbVie's stock to identify patterns and trends that may indicate its future price movements.
The AbbVie stock is traded in Brazil on Sao Paulo Exchange, with the market opening at 10:00:00 and closing at 18:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Brazil. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and AbbVie's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

AbbVie Stock Analysis Notes

The company last dividend was issued on the 12th of January 2023. AbbVie Inc had 1:16 split on the 20th of November 2022. AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 30000 people. For more info on AbbVie Inc please contact Richard Gonzalez at 847 932 7900 or go to https://www.abbvie.com.

AbbVie Market Capitalization

The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.42 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

AbbVie Profitablity

AbbVie's profitability indicators refer to fundamental financial ratios that showcase AbbVie's ability to generate income relative to its revenue or operating costs. If, let's say, AbbVie is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, AbbVie's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of AbbVie's profitability requires more research than a typical breakdown of AbbVie's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.39 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.39.

Technical Drivers

As of the 24th of December, AbbVie shows the mean deviation of 1.54, and Risk Adjusted Performance of 0.0496. AbbVie Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

AbbVie Inc Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. AbbVie middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for AbbVie Inc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

AbbVie Predictive Daily Indicators

AbbVie intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of AbbVie stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

AbbVie Forecast Models

AbbVie's time-series forecasting models are one of many AbbVie's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary AbbVie's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About AbbVie Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how AbbVie prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling AbbVie shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as AbbVie. By using and applying AbbVie Stock analysis, traders can create a robust methodology for identifying AbbVie entry and exit points for their positions.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. ABBVIE DRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 30000 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AbbVie to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data